Trade War

Israel's formula recalls exposed a shared ingredient risk across imported brands

The expansion of Nutrilon withdrawals in February showed how ingredient tracing and changing safety thresholds can widen an import recall beyond a manufacturer's initial list.

Companies and supply chains 17 November 2026

Israel's expansion of the Nutrilon infant-formula recall in February 2026 followed a supply-chain problem involving an ingredient used by several manufacturers. Ynet reported that Teva added products with another eighteen production dates to its withdrawal, replacing an earlier notice dated 30 January 2026. The Health Ministry required a broader withdrawal than the manufacturer's initial list.1

The supplier mattered as much as the brand

According to Ynet's account of the company and ministry statements, the concern centred on arachidonic acid oil, an ingredient supplied to Nutricia by an outside producer. The Israeli instruction covered batches using material from that supplier. Other products using different ingredients were distinguished from the affected list. This was a batch-specific withdrawal, rather than a finding that every product sold under the brand was contaminated.1

The report described the expansion in the language of precaution:

מטעמי זהירות מונעת

As a preventive precaution.1

A joint European investigation dated 19 February 2026 traced contaminated oil to a Chinese producer and through intermediate suppliers into multiple manufacturers' products. Eight food companies had initiated recalls by the assessment's publication. The account illustrates why checking the finished product's country of manufacture alone could not identify the entire affected supply chain: the same ingredient reached factories through different commercial relationships.4

Scientific thresholds changed the scope of withdrawals

France's Agriculture Ministry said on 30 January 2026 that it was lowering the threshold used for cereulide, the toxin involved, while awaiting a European assessment. It asked manufacturers to reassess their products and said further recalls could follow. Its announcement described checks in shops and pharmacies alongside manufacturers' own investigations. A larger withdrawal list therefore did not necessarily mean that a new contamination event had occurred after the first recall.3

On 2 February 2026, the European Food Safety Authority published an acute risk assessment. It used vomiting as the critical effect and added protection for very young infants when calculating an acute reference dose. Its corresponding concentrations related to prepared liquid formula, an important distinction from the concentration in powder before preparation. These were scientific calculations to support risk management, not an announcement that an Israeli import duty or customs rule had changed.2

EFSA also explained that the assessment answered an urgent European Commission request. The work connected toxicological evidence with estimates of infant formula consumption, providing authorities with a common basis for deciding which products required action.2

A recall did not establish every reported illness

The joint European assessment explicitly separated reports of illness after formula consumption from confirmed causal findings. Diagnostic limitations complicated the investigations. It judged exposure less likely following withdrawals and interruption of the ingredient's trade, while warning that recalled products could remain in households. Its unresolved question was whether particular recalled or additional batches explained the illnesses under investigation, not whether every reported case had already been linked to a product.4

Sources

  1. Ynet. נוטרילון בריקול ענק: עוד מוצרים יורדים מהמדפים [Nutrilon in a major recall: more products removed from shelves]. Accessed 17 November 2026Israel's camp · press reporting company and ministry statements · in Hebrew
  2. European Food Safety Authority. L'EFSA fournit une évaluation rapide des risques liés à la céréulide dans les préparations pour nourrissons [EFSA provides a rapid risk assessment of cereulide in infant formula]. 2 February 2026European Union's camp · scientific authority · in French
  3. French Agriculture Ministry. Retraits et rappels de laits infantiles : la France abaisse le seuil pour la toxine céréulide afin de renforcer la protection des nourrissons [Infant-formula withdrawals and recalls: France lowers the cereulide threshold to strengthen infant protection]. 30 January 2026France's camp · government · in French
  4. European Centre for Disease Prevention and Control and European Food Safety Authority. Multi-country foodborne event caused by cereulide in infant formula products. 19 February 2026European Union's camp · scientific assessment

All articles